Conestoga Capital Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.6M | Buy |
107,907
+35,900
| +50% | +$7.85M | 0.35% | 52 |
|
|
2025
Q1 | $16.1M | Buy |
72,007
+4,820
| +7% | +$1.08M | 0.24% | 59 |
|
|
2024
Q4 | $22M | Buy |
67,187
+25,110
| +60% | +$8.23M | 0.29% | 60 |
|
|
2024
Q3 | $12.6M | Buy |
42,077
+260
| +0.6% | +$78K | 0.17% | 65 |
|
|
2024
Q2 | $13.8M | Buy |
41,817
+6,099
| +17% | +$2.01M | 0.21% | 65 |
|
|
2024
Q1 | $14.1M | Sell |
35,718
-19,635
| -35% | -$7.77M | 0.2% | 63 |
|
|
2023
Q4 | $19.5M | Sell |
55,353
-1,040
| -2% | -$366K | 0.29% | 58 |
|
|
2023
Q3 | $21.2M | Sell |
56,393
-1,949
| -3% | -$731K | 0.36% | 56 |
|
|
2023
Q2 | $22.3M | Sell |
58,342
-3,226
| -5% | -$1.23M | 0.35% | 56 |
|
|
2023
Q1 | $21.3M | Buy |
61,568
+260
| +0.4% | +$90.1K | 0.36% | 56 |
|
|
2022
Q4 | $14.4M | Buy |
61,308
+1,235
| +2% | +$291K | 0.27% | 60 |
|
|
2022
Q3 | $14.8M | Buy |
60,073
+1,140
| +2% | +$281K | 0.29% | 60 |
|
|
2022
Q2 | $17.8M | Sell |
58,933
-13,363
| -18% | -$4.04M | 0.32% | 58 |
|
|
2022
Q1 | $29.7M | Buy |
72,296
+338
| +0.5% | +$139K | 0.45% | 48 |
|
|
2021
Q4 | $33.7M | Sell |
71,958
-15,175
| -17% | -$7.12M | 0.44% | 49 |
|
|
2021
Q3 | $37M | Sell |
87,133
-13,886
| -14% | -$5.9M | 0.51% | 48 |
|
|
2021
Q2 | $36.3M | Buy |
101,019
+3,208
| +3% | +$1.15M | 0.52% | 48 |
|
|
2021
Q1 | $27.6M | Buy |
97,811
+2,549
| +3% | +$718K | 0.42% | 51 |
|
|
2020
Q4 | $27M | Buy |
95,262
+5,035
| +6% | +$1.43M | 0.43% | 51 |
|
|
2020
Q3 | $24.8M | Buy |
90,227
+12,017
| +15% | +$3.3M | 0.5% | 51 |
|
|
2020
Q2 | $17.8M | Sell |
78,210
-3,415
| -4% | -$776K | 0.39% | 53 |
|
|
2020
Q1 | $12.4M | Buy |
81,625
+42,038
| +106% | +$6.4M | 0.36% | 53 |
|
|
2019
Q4 | $5.95M | Buy |
39,587
+1,069
| +3% | +$161K | 0.14% | 56 |
|
|
2019
Q3 | $5.46M | Sell |
38,518
-1,285
| -3% | -$182K | 0.14% | 56 |
|
|
2019
Q2 | $4.98M | Buy |
39,803
+520
| +1% | +$65.1K | 0.12% | 57 |
|
|
2019
Q1 | $4.33M | Buy |
39,283
+6,745
| +21% | +$743K | 0.12% | 61 |
|
|
2018
Q4 | $3.19M | Sell |
32,538
-1,070
| -3% | -$105K | 0.1% | 65 |
|
|
2018
Q3 | $4.15M | Buy |
33,608
+6,110
| +22% | +$754K | 0.11% | 58 |
|
|
2018
Q2 | $2.73M | Buy |
27,498
+1,200
| +5% | +$119K | 0.09% | 64 |
|
|
2018
Q1 | $2.32M | Buy |
26,298
+5,305
| +25% | +$468K | 0.09% | 62 |
|
|
2017
Q4 | $2.07M | Sell |
20,993
-5,000
| -19% | -$493K | 0.08% | 65 |
|
|
2017
Q3 | $2.5M | Buy |
25,993
+14,218
| +121% | +$1.37M | 0.11% | 58 |
|
|
2017
Q2 | $1.11M | Buy |
11,775
+650
| +6% | +$61.4K | 0.06% | 67 |
|
|
2017
Q1 | $908K | Buy |
+11,125
| New | +$908K | 0.05% | 68 |
|